Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable fatty-acyl-CoA binding activity. Predicted to be involved in fatty acid metabolic process. Predicted to be active in cytoplasm. Is expressed in liver and liver lobe. Orthologous to human ACBD4 (acyl-CoA binding domain containing 4).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.